ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TRX Tissue Regenix Group Plc

58.00
0.00 (0.00%)
13 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tissue Regenix Group Plc LSE:TRX London Ordinary Share GB00BNTXR104 ORD 0.1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.00% 58.00 48,121 16:35:26
Bid Price Offer Price High Price Low Price Open Price
58.00 61.00 59.50 58.00 58.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations USD 29.49M USD -302k USD -0.0043 -138.37 40.93M
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:26 UT 5,892 58.00 GBX

Tissue Regenix (TRX) Latest News (1)

Tissue Regenix (TRX) Discussions and Chat

Tissue Regenix (TRX) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-12-13 16:35:2658.005,8923,417.36UT
2024-12-13 16:07:4058.0014282.36O
2024-12-13 16:07:4061.00106.10O
2024-12-13 16:07:4058.001,422824.76O
2024-12-13 16:07:4058.00676392.08O

Tissue Regenix (TRX) Top Chat Posts

Top Posts
Posted at 13/12/2024 08:20 by Tissue Regenix Daily Update
Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 58p.
Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £41,991,808.
Tissue Regenix has a price to earnings ratio (PE ratio) of -138.37.
This morning TRX shares opened at 58p
Posted at 25/11/2024 16:21 by timmy40
Presumably the management are impatient with the share price. They have repositioned the company, increased the supply chain and revenue, but the share price has hardly moved for years now. They could always move the listing to the US, but a sale would seem like a reasonable option, although, we're not going to vote in favour without a decent premium imo
Posted at 25/11/2024 08:33 by bamboo2
PJ84, I don't have email access during the day [no signal!], but can try later.

I'll have a think how to angle it. I am almost certain that if they replied, I would not be allowed to share the info. I wonder if another route might be possible, via email to Research Tree or direct to significant investors in TRX?
Posted at 24/11/2024 23:35 by pj84
bamboo2 TRX can and obviously have accessed the article they referred you to.

Just checked the Betaville subscription rate and £5,000/qtr. (non-refundable is a bit steep for private investors)

Maybe a polite follow up email might elicit a bit more information from TRX?
Posted at 24/11/2024 22:42 by bamboo2
It does seem odd that TRX should take the opinion of one insignificant paywalled website so seriously. In this sort of situation the onus is on the company to bring ALL of the information into the public domain for the attention of ALL shareholders.

I am probably being naïve, but it doesn't seem right that some of the information is only available to those with the means to pay for private access.
Posted at 24/11/2024 22:25 by p1nkfish
Looks dodgy all round. Hardly "media" that has much impact and TRX acting on it seems a little extreme. Anyone could set up a website and pass rumours.

One take, if not a p&d is there is no smoke without fire but how would a paywalled site find out. Again, a bit dodgy.
Posted at 24/11/2024 19:45 by pj84
bamboo2 thanks for posting

I have tried to search for any other reference to the news and apart from the paywalled link the only other news I can find relates to the RNS that TRX issued which does seem strange.

The major investors on the website as at 25 September owned just above 50% and to date I haven't seen any of them selling.

If nothing happens then I suspect we won't hear anymore.
Posted at 21/11/2024 12:20 by bamboo2
PJ/anyone Re, "Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy."
=============

Have we had sight of, or a link to the media speculation?
Posted at 04/11/2024 17:27 by bamboo2
I could find no media speculation with a quick google search.
It does look to me like an offer has been made. Maybe it's too low?

====================================================================

Response to media speculation

Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy.



The Company has not received any indicative non-binding proposals to date.



There can be no certainty that any offer will be made as a result of contact with these potential counterparties, nor as to the terms on which any such offer might be made. Shareholders are advised to take no action at this time.



A further announcement will be made in due course.



Takeover Code notes

The Takeover Panel Executive has granted a dispensation from the requirement of Rules 2.4 (a) and (b) of the Takeover Code such that Tissue Regenix is not required to identify in this announcement any potential offeror with which the Company is in talks, or from which an approach has been received, unless that potential offeror has been specifically identified in any rumour or speculation.



As a consequence of this announcement, an 'offer period' has now commenced in respect of the Company in accordance with the Takeover Code, and the attention of shareholders is drawn to the disclosure requirements of Rule 8 of the Takeover Code, which are summarised below in "Disclosure Requirements of the Takeover Code".
Posted at 12/9/2024 08:40 by tnt99
We made a profit at last should this continue and accelerate should see some positive share price reaction Must be at least double this price to bring me back to where I started in 2018 Doh!!!
Posted at 11/8/2022 10:11 by livewireplus
:-)) unfortunately no refunds ... but had some good times ... have ended-up married - but as wife earns more than me then can't complain .... pass the Tissue from the left-hand side. An interesting week so far for the TRX share price ....
Tissue Regenix share price data is direct from the London Stock Exchange

Tissue Regenix Frequently Asked Questions (FAQ)

What is the current Tissue Regenix share price?
The current share price of Tissue Regenix is 58p.
How many Tissue Regenix shares are in issue?
Tissue Regenix has 70,574,468 shares in issue.
What is the market cap of Tissue Regenix?
The market capitalisation of Tissue Regenix is GBP 40.93 M.
What is the 1 year trading range for Tissue Regenix share price?
Tissue Regenix has traded in the range of 50.50p to 74.00p during the past year.
What is the PE ratio of Tissue Regenix?
The price to earnings ratio of Tissue Regenix is -138.37.
What is the cash to sales ratio of Tissue Regenix?
The cash to sales ratio of Tissue Regenix is 1.42.
What is the reporting currency for Tissue Regenix?
Tissue Regenix reports financial results in USD.
What is the latest annual turnover for Tissue Regenix?
The latest annual turnover of Tissue Regenix is USD 29.49M.
What is the latest annual profit for Tissue Regenix?
The latest annual profit of Tissue Regenix is USD -302k.
What is the registered address of Tissue Regenix?
The registered address for Tissue Regenix is UNIT 3, PHOENIX COURT, LOTHERTON WAY, LEEDS, LS25 2GY.
What is the Tissue Regenix website address?
The website address for Tissue Regenix is www.tissueregenix.com.
Which industry sector does Tissue Regenix operate in?
Tissue Regenix operates in the PHARMACEUTICAL PREPARATIONS sector.

Your Recent History

Delayed Upgrade Clock